Advances and prospects in tumor infiltrating lymphocyte therapy
Abstract Tumor-infiltrating lymphocyte (TIL) therapy in adoptive T-cell therapy (ACT) has already caused durable regression in a variety of cancer types due to T-cell persistence, clinical activity, and duration of objective response and safety. TILs are composed of polyclonal effector T-cells speci...
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Springer
2024-11-01
|
| Colecção: | Discover Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s12672-024-01410-5 |